These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 15178639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S.
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [Abstract] [Full Text] [Related]

  • 3. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
    Gokturk C, Nordquist J, Sugimoto H, Forsberg-Nilsson K, Nilsson J, Oreland L.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):1013-20. PubMed ID: 15541390
    [Abstract] [Full Text] [Related]

  • 4. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
    Boomsma F, Hut H, Bagghoe U, van der Houwen A, van den Meiracker A.
    Med Sci Monit; 2005 Apr 17; 11(4):RA122-6. PubMed ID: 15795708
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
    Abella A, García-Vicente S, Viguerie N, Ros-Baró A, Camps M, Palacín M, Zorzano A, Marti L.
    Diabetologia; 2004 Mar 17; 47(3):429-438. PubMed ID: 14968297
    [Abstract] [Full Text] [Related]

  • 9. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
    Bour S, Daviaud D, Gres S, Lefort C, Prévot D, Zorzano A, Wabitsch M, Saulnier-Blache JS, Valet P, Carpéné C.
    Biochimie; 2007 Aug 17; 89(8):916-25. PubMed ID: 17400359
    [Abstract] [Full Text] [Related]

  • 10. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
    Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, Salmi M.
    Eur J Immunol; 2004 Aug 17; 34(8):2276-85. PubMed ID: 15259025
    [Abstract] [Full Text] [Related]

  • 11. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
    Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J.
    Cerebrovasc Dis; 2012 Aug 17; 33(1):55-63. PubMed ID: 22133888
    [Abstract] [Full Text] [Related]

  • 12. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme.
    Bonaiuto E, Lunelli M, Scarpa M, Vettor R, Milan G, Di Paolo ML.
    Biochimie; 2010 Jul 17; 92(7):858-68. PubMed ID: 20298739
    [Abstract] [Full Text] [Related]

  • 13. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P, Solé M, Unzeta M.
    Cerebrovasc Dis; 2014 Jul 17; 37(3):171-80. PubMed ID: 24503888
    [Abstract] [Full Text] [Related]

  • 14. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients.
    Koc-Zorawska E, Malyszko J, Malyszko JS, Mysliwiec M.
    Kidney Blood Press Res; 2012 Jul 17; 36(1):242-7. PubMed ID: 23154672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R, Adams DH, Leino R, Möttönen T, Jalkanen S, Salmi M.
    J Immunol; 1998 Aug 01; 161(3):1549-57. PubMed ID: 9686623
    [Abstract] [Full Text] [Related]

  • 18. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
    Mészáros Z, Csányi A, Vallus G, Szombathy T, Karádi I, Magyar K.
    Neurobiology (Bp); 2000 Aug 01; 8(2):215-23. PubMed ID: 11061216
    [Abstract] [Full Text] [Related]

  • 19. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
    Yraola F, García-Vicente S, Fernandez-Recio J, Albericio F, Zorzano A, Marti L, Royo M.
    J Med Chem; 2006 Oct 19; 49(21):6197-208. PubMed ID: 17034126
    [Abstract] [Full Text] [Related]

  • 20. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
    Yu PH, Lu LX, Fan H, Kazachkov M, Jiang ZJ, Jalkanen S, Stolen C.
    Am J Pathol; 2006 Mar 19; 168(3):718-26. PubMed ID: 16507887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.